Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. (MD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
md · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pediatrix Medical Group, Inc. (MD) measures how much investors pay for each dollar of the company's trailing earnings. MD's current PE ratio of 10.75x is calculated by dividing its stock price of $22.55 by its TTM earnings per share of $2.10. −27.5% discount vs 5Y avg 14.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%17.2x
MedianQ3 · 75%23.1x
Max
At 10.75x, MD's current P/E is lower than in 6% of its annual fiscal year readings over the past 16 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pediatrix Medical Group, Inc.You MD | $1.9B | 10.75x | -58.4% | $2.10 |
 Acadia Healthcare Company, Inc. ACHC | $2.3B | N/A | — | -$12.16 |
 Addus HomeCare Corporation ADUS | $1.7B | 20.66x | -20.2% | $5.20 |
 Ardent Health Partners, LLC ARDT | $1.2B | 9.15x | -64.6% | $0.96 |
 Astrana Health, Inc. ASTH | $1.9B | 54.15x | +109.2% | $0.46 |
 Aveanna Healthcare Holdings Inc. AVAH | $1.4B | 7.31x | -71.8% | $1.11 |
 Guardian Pharmacy Services, Inc. GRDN | $2.6B | 38.14x | +47.4% | $0.79 |
Industry Average 5 peers with valid PE | — | 25.88x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 11.03x | $1.94 | — | |
2024-12-31 FY2024 | — | $-1.19 | — | |
2023-12-31 FY2023 | — | $-0.72 | — | |
2022-12-31 FY2022 | 18.58x | $0.80 | +3.5% | |
2021-12-31 FY2021 | 17.96x | $1.52 | — | |
2020-12-31 FY2020 | — | $-9.31 | — | |
2019-12-31 FY2019 | — | $-17.78 | — | |
2018-12-31 FY2018 | 11.19x | $2.95 | -27.4% | |
2017-12-31 FY2017 | 15.42x | $3.47 | -18.7% | |
2016-12-31 FY2016 | 18.96x | $3.52 | -5.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pediatrix Medical Group, Inc. (MD) measures how much investors pay for each dollar of the company's trailing earnings. MD's current PE ratio of 10.75x is calculated by dividing its stock price of $22.55 by its TTM earnings per share of $2.10.
Frequently asked questions
MD pe ratio · 6 questionsMD's current PE ratio is 10.75x as of 2026-06-08, based on a stock price of $22.55 and TTM EPS of $2.10. Data sourced from Financial Modeling Prep via MD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pediatrix Medical Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08